IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

M28 Capital Management LP

Q1 2024 Holdings

Filed 2024-05-14 | 11 holdings | $135.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Wave Life Sciences LTD(WVE)SHSY95308105$43.2M7,000,00031.9%
Invivyd Inc(IVVD)COM00534A102$41.1M9,248,25030.3%
Fractyl Health Inc(GUTS)COM35168W103$13.7M1,856,11710.1%
Rocket Pharmaceuticals Inc(RCKT)COM77313F106$10.4M385,6807.7%
Silence Therapeutics PLC(SLN)ADS82686Q101$6.5M299,4004.8%
Springworks Therapeutics IncCOM85205L107$5.4M110,4004.0%
Curis Inc(CRIS)COM231269309$4.6M421,9513.4%
Bridgebio Pharma Inc(BBIO)COM10806X102$3.7M121,2002.8%
TG Therapeutics Inc(TGTX)COM88322Q108$2.5M161,6001.8%
Proqr Thrapeutics N VSHS EURON71542109$2.3M1,019,4981.7%
Arrowhead Pharmaceuticals in(ARWR)COM04280A100$1.9M67,4001.4%